MKI67 and breast carcinoma: These findings are important given the increasing need to incorporate measures of KI67 as part of tools that are needed to refine prognostic scores for breast cancer patients; this is especially relevant for patients with ER-positive, node-negative tumours, in order to aid decisions on providing adjuvant chemotherapy.